Expertise in
3
conditions

Jeremy P. Grummet

St. Vincent's Hospital Melbourne
Melbourne, VIC, AU 
Expertise in
3
conditions
St. Vincent's Hospital Melbourne
Melbourne, VIC, AU 
OverviewLocationsClinical Research

Overview

Jeremy Grummet practices in Melbourne, Australia. Mr. Grummet is highly rated in 3 conditions, according to our data. His top areas of expertise are Prostate Cancer, Sepsis, Renal Cell Carcinoma (RCC), Prostatectomy, and Reconstructive Urology Surgery.

His clinical research consists of co-authoring 86 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

St. Vincent's Hospital Melbourne
Melbourne, VIC, Australia
Other Locations
125 Balaclava Road, Caulfield North, VIC 3161, Australia
55 Commercial Road, Melbourne, VIC 3004, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Randomised Phase 3 Trial of Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer: ENZAMET
Randomised Phase 3 Trial of Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer: ENZAMET
Enrollment Status: Active_not_recruiting
Publish Date: February 06, 2025
Intervention Type: Drug
Study Drugs: Enzalutamide, Non-Steroidal Anti Androgen, Luteinizing Hormone Releasing Hormone Analog or Surgical Castration
Study Phase: Phase 3
A Study to Establish the Feasibility of Biolen for the Local Delivery of Bicalutamide in Patients With Prostate Cancer
A Study to Establish the Feasibility of Biolen for the Local Delivery of Bicalutamide in Patients With Prostate Cancer
Enrollment Status: Completed
Publish Date: June 24, 2024
Intervention Type: Combination product
Study Drug: Bicalutamide
Study Phase: Phase 1
Adding Mitomycin to Bacillus of Calmette-Guerin (BCG) as Adjuvant Intravesical Therapy for High-risk, Non-Muscle-invasive Bladder Cancer: a Randomised Phase 3 Trial
Adding Mitomycin to Bacillus of Calmette-Guerin (BCG) as Adjuvant Intravesical Therapy for High-risk, Non-Muscle-invasive Bladder Cancer: a Randomised Phase 3 Trial
Enrollment Status: Unknown
Publish Date: June 18, 2023
Intervention Type: Drug, Biological
Study Drugs: Bacillus of Calmette-Guerin, Mitomycin C
Study Phase: Phase 3
View 2 Less Clinical Trials

86 Total Publications

Re: Rajal B. Shah, Gladell P. Paner, Liang Cheng, et al. Genitourinary Pathology Society and International Society of Urological Pathology White Paper on Defining Indolent Prostate Cancer: Call for a Multidisciplinary Approach. Eur Urol. 2025;88:8-10.
Re: Rajal B. Shah, Gladell P. Paner, Liang Cheng, et al. Genitourinary Pathology Society and International Society of Urological Pathology White Paper on Defining Indolent Prostate Cancer: Call for a Multidisciplinary Approach. Eur Urol. 2025;88:8-10.
Journal: European urology
Published: April 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Grummet's expertise for a condition
ConditionClose
    View All 7 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile